133 related articles for article (PubMed ID: 3106656)
1. Addition of sulfonylurea to insulin treatment in poorly controlled type II diabetes. A double-blind, randomized clinical trial.
Schade DS; Mitchell WJ; Griego G
JAMA; 1987 May; 257(18):2441-5. PubMed ID: 3106656
[TBL] [Abstract][Full Text] [Related]
2. Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism.
Osei K; O'Dorisio TM; Falko JM
Am J Med; 1984 Dec; 77(6):1002-9. PubMed ID: 6439036
[TBL] [Abstract][Full Text] [Related]
3. Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation.
Falko JM; Osei K
Am J Med; 1985 Sep; 79(3B):92-101. PubMed ID: 3931467
[TBL] [Abstract][Full Text] [Related]
4. A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.
Burge MR; Schmitz-Fiorentino K; Fischette C; Qualls CR; Schade DS
JAMA; 1998 Jan; 279(2):137-43. PubMed ID: 9440664
[TBL] [Abstract][Full Text] [Related]
5. Effects of combined insulin-sulfonylurea therapy in type II patients.
Lewitt MS; Yu VK; Rennie GC; Carter JN; Marel GM; Yue DK; Hooper MJ
Diabetes Care; 1989 Jun; 12(6):379-83. PubMed ID: 2499443
[TBL] [Abstract][Full Text] [Related]
6. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial.
Yki-Järvinen H; Ryysy L; Nikkilä K; Tulokas T; Vanamo R; Heikkilä M
Ann Intern Med; 1999 Mar; 130(5):389-96. PubMed ID: 10068412
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.
DeFronzo RA; Goodman AM
N Engl J Med; 1995 Aug; 333(9):541-9. PubMed ID: 7623902
[TBL] [Abstract][Full Text] [Related]
8. Serum C-peptide levels determine glycemic responses in type II diabetic patients treated with combined insulin and sulfonylurea agent.
Osei K; Falko JM
Am J Med Sci; 1985 Apr; 289(4):148-53. PubMed ID: 3920907
[TBL] [Abstract][Full Text] [Related]
9. [Combined treatment of type-2 diabetics with insulin and glibenclamide after secondary drug failure. Double-blind, insulin-placebo-controlled crossover study].
Rosak C; Schwarz O; Althoff PH; Schöffling K; Schmidt FH
Dtsch Med Wochenschr; 1985 Dec; 110(51-52):1975-80. PubMed ID: 3935405
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.
Hermann LS; Scherstén B; Bitzén PO; Kjellström T; Lindgärde F; Melander A
Diabetes Care; 1994 Oct; 17(10):1100-9. PubMed ID: 7821128
[TBL] [Abstract][Full Text] [Related]
11. Combined therapy for obese type 2 diabetes: suppertime mixed insulin with daytime sulfonylurea.
Riddle M; Hart J; Bingham P; Garrison C; McDaniel P
Am J Med Sci; 1992 Mar; 303(3):151-6. PubMed ID: 1595776
[TBL] [Abstract][Full Text] [Related]
12. Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study.
Nathan DM; Roussell A; Godine JE
Ann Intern Med; 1988 Mar; 108(3):334-40. PubMed ID: 3124685
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.
Riddle MC; Hart JS; Bouma DJ; Phillipson BE; Youker G
Diabetes Care; 1989 Oct; 12(9):623-9. PubMed ID: 2507265
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of sulfonylurea responsiveness in NIDDM. Randomized double-blind study of intermittent glyburide therapy.
Grunberger G
Diabetes Care; 1992 May; 15(5):696-9. PubMed ID: 1516489
[TBL] [Abstract][Full Text] [Related]
15. The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial.
Yale JF; Valiquett TR; Ghazzi MN; Owens-Grillo JK; Whitcomb RW; Foyt HL
Ann Intern Med; 2001 May; 134(9 Pt 1):737-45. PubMed ID: 11329231
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.
Dills DG; Schneider J
Horm Metab Res; 1996 Sep; 28(9):426-9. PubMed ID: 8911977
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of addition of oral spray insulin (Oralin) on insulin secretion and metabolic control in subjects with type 2 diabetes mellitus suboptimally controlled on oral hypoglycemic agents.
Guevara-Aguirre J; Guevara M; Saavedra J; Mihic M; Modi P
Diabetes Technol Ther; 2004 Feb; 6(1):1-8. PubMed ID: 15000763
[TBL] [Abstract][Full Text] [Related]
18. Treatment of type I diabetes with a combination of glyburide and insulin.
Gums JG; Curry RW; Montes de Oca G; Skluth HA; Reynolds LR
Ann Pharmacother; 1992 Jun; 26(6):757-62. PubMed ID: 1611155
[TBL] [Abstract][Full Text] [Related]
19. Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetes.
Hollander PA; Schwartz SL; Gatlin MR; Haas SJ; Zheng H; Foley JE; Dunning BE
Diabetes Care; 2001 Jun; 24(6):983-8. PubMed ID: 11375357
[TBL] [Abstract][Full Text] [Related]
20. Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effect.
Bieger WP; Dlugosch R; Rettenmeier A; Holler HD; Bert H; Schwarz W; Fiehn W; Merkt J; Weicker H
Klin Wochenschr; 1984 Jul; 62(13):631-9. PubMed ID: 6434794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
